Apatinib Combined With Radiotherapy in Patient With BM From Drive Gene Negative NSCLC
NCT03801200
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
90
Enrollment
OTHER
Sponsor class
Conditions
NSCLC
Interventions
DRUG:
Apatinib
Sponsor
Hubei Cancer Hospital